Yi Kong

1.8k total citations
96 papers, 1.4k citations indexed

About

Yi Kong is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Yi Kong has authored 96 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 21 papers in Genetics and 19 papers in Hematology. Recurrent topics in Yi Kong's work include Biochemical and Structural Characterization (21 papers), Venomous Animal Envenomation and Studies (20 papers) and Blood Coagulation and Thrombosis Mechanisms (12 papers). Yi Kong is often cited by papers focused on Biochemical and Structural Characterization (21 papers), Venomous Animal Envenomation and Studies (20 papers) and Blood Coagulation and Thrombosis Mechanisms (12 papers). Yi Kong collaborates with scholars based in China, United States and Myanmar. Yi Kong's co-authors include Xin Ming, Zhenguo Liu, Xingwang Hu, Zebing Huang, Jun Quan, Xuegong Fan, Ji‐Fu Wei, Yahui Chen, Jianfa Zhang and Ying Wang and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and International Journal of Molecular Sciences.

In The Last Decade

Yi Kong

92 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Kong China 20 712 263 217 191 129 96 1.4k
William R. Wolter United States 21 502 0.7× 217 0.8× 85 0.4× 134 0.7× 76 0.6× 47 1.5k
Margaret Dah‐Tsyr Chang Taiwan 27 972 1.4× 142 0.5× 148 0.7× 118 0.6× 227 1.8× 85 1.8k
Ricardo Medina United States 21 1.3k 1.8× 289 1.1× 84 0.4× 195 1.0× 69 0.5× 46 1.8k
Osamu Takeda Japan 20 571 0.8× 218 0.8× 206 0.9× 289 1.5× 61 0.5× 46 1.3k
Takao Fukuda Japan 23 990 1.4× 235 0.9× 84 0.4× 127 0.7× 32 0.2× 85 2.0k
Genshi Zhao United States 27 1.6k 2.3× 464 1.8× 400 1.8× 149 0.8× 72 0.6× 52 2.4k
Xiaoming Wu China 29 1.5k 2.1× 310 1.2× 140 0.6× 78 0.4× 35 0.3× 103 2.5k
Yingqiu Xie Kazakhstan 27 1.1k 1.6× 300 1.1× 187 0.9× 69 0.4× 51 0.4× 80 2.0k
Xingfeng Yin China 23 1.1k 1.5× 302 1.1× 89 0.4× 61 0.3× 53 0.4× 41 1.6k
Bernadette Bouchon France 20 745 1.0× 78 0.3× 136 0.6× 53 0.3× 106 0.8× 46 1.2k

Countries citing papers authored by Yi Kong

Since Specialization
Citations

This map shows the geographic impact of Yi Kong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Kong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Kong more than expected).

Fields of papers citing papers by Yi Kong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Kong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Kong. The network helps show where Yi Kong may publish in the future.

Co-authorship network of co-authors of Yi Kong

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Kong. A scholar is included among the top collaborators of Yi Kong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Kong. Yi Kong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Pu, Xingxiang, Jia Li, Yan Xu, et al.. (2025). Potential biomarkers of primary resistance to first- and second-generation EGFR-TKIs in non-small-cell lung cancer: a real-world study. Therapeutic Advances in Medical Oncology. 17. 22781368–22781368. 2 indexed citations
4.
Chen, Panpan, Cai Chen, Zhaojun Liu, et al.. (2024). Discovery of 2,3-Dihydro[1,4]dioxino[2,3-g]benzofuran Derivatives as Protease Activated Receptor 4 (PAR4) Antagonists with Potent Antiplatelet Aggregation Activity and Low Bleeding Tendency. Journal of Medicinal Chemistry. 67(7). 5502–5537. 1 indexed citations
5.
Tang, Rong, Yaqiong Zhang, Dong‐Bao Hu, et al.. (2019). New Amides and Phenylpropanoid Glucosides from the Fruits of Piper retrofractum. Natural Products and Bioprospecting. 9(3). 231–241. 9 indexed citations
7.
Zhao, Yan, et al.. (2017). RGD-Modified Albumin Nanoconjugates for Targeted Delivery of a Porphyrin Photosensitizer. Molecular Pharmaceutics. 14(8). 2793–2804. 53 indexed citations
8.
Li, Zhoukun, Jie Zhou, Xianfeng Ye, et al.. (2017). A debranching enzyme IsoM of Corallococcus sp. strain EGB with potential in starch processing. International Journal of Biological Macromolecules. 105(Pt 1). 1300–1309. 11 indexed citations
9.
Ding, Xue, Zhouling Xie, Qi Zhao, et al.. (2016). A Naphthalenic Derivative ND-1 Inhibits Thrombus Formation by Interfering the Binding of Fibrinogen to Integrin αIIbβ3. BioMed Research International. 2016. 1–8. 4 indexed citations
10.
Kong, Yi, et al.. (2016). Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America (Part IV). 26(22). 5280. 1 indexed citations
11.
Wang, Ying, et al.. (2016). The pyrrolidinoindoline alkaloid Psm2 inhibits platelet aggregation and thrombus formation by affecting PI3K/Akt signaling. Acta Pharmacologica Sinica. 37(9). 1208–1217. 31 indexed citations
12.
Yang, Hong‐Ling, Shen Zhi-qiang, Xuan Liu, & Yi Kong. (2016). Two novel antimicrobial peptides from skin venoms of spadefoot toad Megophrys minor. Chinese Journal of Natural Medicines. 14(4). 294–298. 13 indexed citations
13.
Liu, Xuan, Caihui Wang, Xue Ding, et al.. (2016). A novel selective inhibitor to thrombin-induced platelet aggregation purified from the leech Whitmania pigra. Biochemical and Biophysical Research Communications. 473(1). 349–354. 31 indexed citations
14.
Chen, Yahui, et al.. (2015). A tryptophan derivative TD-26 attenuates thrombus formation by inhibiting both PI3K/Akt signaling and binding of fibrinogen to integrin αIIbβ3. Biochemical and Biophysical Research Communications. 465(3). 516–522. 9 indexed citations
15.
Xiong, Jing, Li Bai, Wei Fang, et al.. (2012). New peptide pENW (pGlu-Asn-Trp) inhibits platelet activation by attenuating Akt phosphorylation. European Journal of Pharmaceutical Sciences. 45(5). 552–558. 11 indexed citations
16.
Kong, Yi, Shilong Huang, Shaoqing Yu, Shuai Li, & Ji‐Fu Wei. (2012). Purification and characterization of a novel antithrombotic peptide from Scolopendra subspinipes mutilans. Journal of Ethnopharmacology. 145(1). 182–186. 45 indexed citations
17.
Zhao, Hongwen, Yi Kong, Hanjin Wang, et al.. (2011). A defensin‐like antimicrobial peptide from the venoms of spider, Ornithoctonus hainana. Journal of Peptide Science. 17(7). 540–544. 22 indexed citations
18.
Xiong, Jing, et al.. (2009). Anticoagulant and antithrombotic activity of a new peptide pENW (pGlu-Asn-Trp). Journal of Pharmacy and Pharmacology. 61(1). 89–94. 13 indexed citations
19.
Kong, Yi. (2009). Peptide mapping analysis of Exenatide by LC-MS spectrometry. Huaxi yaoxue zazhi. 1 indexed citations
20.
Kong, Yi. (2008). Effects of Grifola frondosa maitake polysaccharides on mice with 2-diabetes. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026